MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02278nam a22003737a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
e7b3ced1-1aa0-4c44-9f10-c6bdd14cdc2c |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
KnowledgeUnlatched |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20210303104746.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr u|||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
210129p20202020xx o u00| u eng d |
| 037 ## - SOURCE OF ACQUISITION |
|---|
| Institution to which field applies |
BiblioBoard |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781789858983 |
| 024 8# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
https://doi.org/10.5772/intechopen.88376 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) |
|---|
| OCLC library identifier |
https://library.biblioboard.com/ext/api/media/e7b3ced1-1aa0-4c44-9f10-c6bdd14cdc2c/assets/thumbnail.jpg |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
ScCtBLL |
| Transcribing agency |
ScCtBLL |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Artificial Intelligence in Oncology Drug Discovery and Development |
| Statement of responsibility, etc. |
John W. Cassidy, Belle Taylor. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Name of producer, publisher, distributor, manufacturer |
IntechOpen, |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (1 p.) |
| 506 0# - RESTRICTIONS ON ACCESS NOTE |
|---|
| Terms governing access |
Access copy available to the general public. |
| Standardized terminology for access restriction |
Unrestricted |
| Source of term |
star |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
There exists a profound conflict at the heart of oncology drug development. The efficiency of the drug development process is falling, leading to higher costs per approved drug, at the same time personalised medicine is limiting the target market of each new medicine. Even as the global economic burden of cancer increases, the current paradigm in drug development is unsustainable. In this book, we discuss the development of techniques in machine learning for improving the efficiency of oncology drug development and delivering cost-effective precision treatment. We consider how to structure data for drug repurposing and target identification, how to improve clinical trials and how patients may view artificial intelligence. |
| 588 0# - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Description based on print version record. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
IntechOpen Engineering 2019 - 2021 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Computers / Artificial Intelligence |
| Source of heading or term |
bisacsh |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Computers |
| 655 #0 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Cassidy, John W. |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Taylor, Belle |
| Relator term |
editor. |
| 758 ## - |
|---|
| -- |
Is found in: |
| -- |
Knowledge Unlatched |
| -- |
https://openresearchlibrary.org/module/2774bc74-146a-484f-a7ba-ab1d6a09bbfb |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://openresearchlibrary.org/content/e7b3ced1-1aa0-4c44-9f10-c6bdd14cdc2c">https://openresearchlibrary.org/content/e7b3ced1-1aa0-4c44-9f10-c6bdd14cdc2c</a> |
| Public note |
View this content on Open Research Library. |
| -- |
0 |
